The chimeric cell surface receptor scC2Fv/CD8/ was constructed to engineer primary mouse T lymphocytes with antibody-type specificity to type II collagen (CII). Such cells could be used as gene carriers in the anti-inflammatory gene therapy of an autoimmune arthritis. This receptor includes the single chain Fv domain (scFv) of the anti-CII monoclonal antibody (mAb) C2, hinge region of CD8␣ and the transmembrane and cytoplasmic domains of TCR. The scC2Fv/CD8/ gene was transduced into T cell hybridomas and primary mouse lymphocytes using retrovirus-mediated gene transfer. The chimeric receptor scC2Fv/CD8/ forms covalently bound homodimers, as demonstrated in T cell hybridomas and packaging fibroblasts. It does not associate
Introduction
Clinical therapies based on modulation of cytokines represent an important new approach to the treatment of rheumatoid arthritis. Significant therapeutic effect of TNF␣ blockade with specific antibodies has been demonstrated in rheumatoid arthritis 1 and in its animal model, murine collagen-induced arthritis (CIA). 2 Experimental autoimmune arthritis can be inhibited by a number of proteins modulating cytokine activity, such as soluble TNF receptors, 3, 4 soluble IL-1 receptor antagonist, 5 TGF-␤ 1 , 6 IL-4, 7 IL-10 (reviewed in Ref. 8 ) and galectin-1. 9 It is possible that other known or as yet unknown cytokines and other molecules mediating intercellular interactions in inflammation can be targets for anti-inflammatory therapy.
These immunomodulatory proteins can be manufactured and injected into patients. However, a number of limitations, for example high cost, may restrict clinical application of such anti-inflammatory protein therapy. In principle, many of these limitations can be overcome by gene therapy (reviewed in Ref. 10 ). In addition, gene therapy opens up a few possibilities for more adequate antiinflammatory therapy than the one that can be carried with endogenous signalling subunits of the TCR complex. When scC2Fv/CD8/-expressing clones of T cell hybridomas MD. 45 and HCQ6 were stimulated with CII they produced IL-2. The level of their IL-2 response correlated with the expression level of the chimeric receptor on the cell surface. Splenocytes isolated from DBA/1 mice were stimulated with Con A in vitro to facilitate retrovirus-mediated transfer of the scC2Fv/CD8/ gene. As a result of transduction, approximately 4% of the Con A-activated splenocytes expressed the chimeric receptor scC2Fv/CD8/ on the cell surface. These cells proliferated in response to stimulation with CII. Gene Therapy (2000) 7, 714-722.
out by injecting proteins. For example, it is easier to maintain constantly a therapeutic concentration of an anti-inflammatory agent when it is produced by patient's cells transduced with the gene encoding this agent, than when it is administered as a protein. Furthermore, gene therapy might give a better opportunity than protein therapy for reduction of deleterious systemic effects characteristic for many anti-inflammatory agents by targeting their production to the site of inflammation. The balance between local and systemic effects of antiinflammatory gene therapy would depend to a great extent on the type of cells used as carriers of therapeutic genes. Since effector T lymphocytes tend to accumulate in compartments where they encounter their cognate antigens (reviewed in Ref. 11), autoantigen-specific effector T lymphocytes might be able to deliver a therapeutic gene to tissues affected by autoimmune inflammation. Based on this rationale, studies performed by us and other groups have demonstrated that pathogenic lymphocytes ex vivo transduced with a gene encoding an anti-inflammatory protein can exert a therapeutic effect in a number of experimental autoimmune diseases, such as CIA, 4, 12, 13 insulin-dependent diabetes in NOD mice, 14 peripheral neuritis 15 and experimental allergic encephalomyelitis. 16, 17 Cloned Th2 cells also reduced inflammatory reaction in some of these cell-mediated autoimmune diseases as long as these cells were autoantigen specific. [18] [19] [20] [21] [22] CII is a tissue-specific protein in articular cartilage and one of the candidate autoantigens in rheumatoid arthritis. Induction of humoral and cellular immune response to CII leads to the development of CIA in mice. 23 In view of selective expression of CII in articular cartilage, it is possible that effector T cells genetically modified to recognise an unprocessed CII could accumulate in articular cartilage upon adoptive transfer driven by the forces enabling accumulation of normal T cells at the site where they encounter their cognate antigenic peptide/MHC complexes. Such engineered cells could be used as carriers of therapeutic genes. To engineer T cells responsive to CII we cloned a chimeric receptor similar to the one described before. 24 The CII-recognising ectodomain of this receptor consists of the scFv domain of the anti-CII antibody C2 25 fused with the hinge region of CD8␣. To enable signalling upon interaction with CII, this ectodomain is fused with the transmembrane and intracellular domains of the TCR. The cytoplasmic domain of the TCR contains three copies of a conserved sequence with two tyrosine residues called immunoreceptor tyrosinebased activation motif (ITAM) that is a consensus motif of the TCR signalling proteins and FcR signalling ␥ subunit. [26] [27] [28] Phosphorylation of the tyrosine residues within ITAM is one of the major membrane-proximal events in the activation of the TCR signalling pathway. The results reported here demonstrate that scC2Fv/CD8/ is a functionally active cell surface receptor that confers antibodytype specificity to CII on T cell hybridomas and primary mouse T lymphocytes.
Results
Expression and function of scC2Fv/CD8/ in T cell hybridomas T cell hybridomas transduced with scC2Fv/CD8/ were cloned by limiting dilutions, and clones were scanned for the chimera expression by staining with the rabbit antimAb C2 antiserum and FACS analysis. As demonstrated in our previous report, 29 wild-type T cell hybridomas do not express epitopes recognisable by the rabbit anti-mAb C2 antiserum. Four MD.45(C2CD8) and four HCQ6(C2CD8) clones with the highest expression levels ( Figure 1 ) were used in experiments. To assess the ability of scC2Fv/CD8/ to function as a cell surface receptor, wild-type MD.45 or HCQ6 cells, T cell hybridomas transduced with pBabe neo and clones of T cell hybridomas expressing scC2Fv/CD8/ were stimulated with CII, and IL-2 levels in their culture supernatants were measured. In the absence of stimulation, neither wild-type T cell hybridomas nor T cell hybridomas transduced with any of the constructs produced detectable levels of IL-2 ( Figure 2 and Ref. 29) . In response to stimulation with CII added to culture medium or immobilised on plastic, the MD.45(C2CD8) and HCQ6(C2CD8) clones, but not wild-type or pBabe neo-transduced MD.45 and HCQ6 cells, secreted IL-2 in culture medium (Figure 2 ).
There was a correlation between the expression level of the chimera on the cell surface and the magnitude of IL-2 response (compare Figure 1 and Figure 2 ). Thus, among MD.45(C2CD8) clones, the clone 2-2 expressed the highest level of the chimera on the cell surface and mounted the highest IL-2 response to CII, whereas the MD.45(C2CD8) clone 1-10 expressing the lowest level of cell surface scC2Fv/CD8/ was least responsive to CII. Likewise, among HCQ6(C2CD8) clones, the highest expression level in the clone 9-6 was associated with the highest IL-2 secretion, whereas the HCQ6(C2CD8) clone 94-14 demonstrated the lowest level of the chimera expression and IL-2 secretion at the same time. Of interest, a two-to three-fold difference in the scC2Fv/CD8/ expression on the cell surface manifested in more than a 10-fold difference in the magnitude of IL-2 response.
As expected, when wild-type MD.45 or HCQ6 cells were stimulated with plastic-immobilised anti-CD3⑀ mAb 145-2C11, 30 high levels of IL-2 were detected in culture medium (Figure 3 ). In the presence of DBA/1 splenocytes as antigen presenting cells, wild-type HCQ6 cells do respond to CII by IL-2 secretion. 29, 31 However, the HCQ6(C2CD8) and MD.45(C2CD8) clones were virtually unresponsive to stimulation with plastic-immobilised anti-CD3⑀ ( Figure 3 ). This unresponsiveness did not result from expression of a retroviral vector, because the levels of IL-2 production in response to stimulation with
Figure 2 CII-induced IL-2 secretion from MD.45(C2CD8) and HCQ6(C2CD8) clones. MD.45 and HCQ6 cells transduced with pBabe neo, or MD.45(C2CD8) and HCQ6(C2CD8) clones were stimulated overnight with CII added to culture medium or attached to plastic. IL-2 content in culture supernatants was measured by IL-2 ELISA. Results are presented as mean of duplicates.

Figure 3 Decreased response to anti-CD3⑀ in T cell hybridomas expressing scC2Fv/CD8/. Wild-type T cell hybridomas, MD.45(C2CD8) clones and HCQ6(C2CD8) clones were stimulated with anti-CD3⑀ mAb 145-2C11 immobilised on plastic at indicated concentrations in duplicates. IL-2 concentration in culture medium was measured by ELISA.
anti-CD3⑀ were similar in T cell hybridomas transduced with a retroviral vector and in the wild-type cells. 29 The expression levels of CD3⑀ on the surface of the chimeratransduced T cell hybridoma clones were reduced to various extents (not shown) partially explaining the loss of responsiveness through the endogenous TCR complex.
Subunit organisation of scC2Fv/CD8/ expressed in T cell hybridomas To determine the subunit structure of scC2Fv/CD8/ expressed on the surface of T cell hybridomas, wild-type T cell hybridomas, MD.45(C2CD8) clone 2-2 and HCQ6(C2CD8) clone 9-2 were cell surface biotinylated and lysed. Proteins immunoprecipitated from these lysates with anti-mAb C2 anti-serum were separated by SDS-PAGE. Only a single band with apparent m.w. of 54.8 ± 3.5 kDa (mean ± s.d., four experiments) was present on the gel run under reducing conditions ( Figure  4a ). This band represents a monomeric scC2Fv/CD8/ (predicted m.w. 48.3 kDa). Under non-reducing conditions, a protein with apparent m.w. of 121 ± 10 kDa (mean ± s.d., four experiments) representing a homodimer of scC2Fv/CD8/ was revealed in the immunoprecipitates of surface-biotinylated hybridoma cells ( Figure  4a ). Obviously, formation of divalent homodimers by cell surface-expressed chimeric receptors increases their avidity for CII. As shown in Figure 4b , immunoblotting of SDS-PAGE separated proteins with anti-mAb C2 antiserum also demonstrated that the 121 kDa band was the major band present in lysates of MD.45(C2CD8) and HCQ6(C2CD8) clones, as well as in lysates of packaging scC2Fv/CD8/-transduced GP+E86 fibroblasts. Low intensity bands of other m.w. were also present in cells lysates ( Figure 4) . However, there were no bands which were expressed in T cell hybridomas but not in packaging fibroblasts. This argues against association of the chimera with endogenous T cell-specific proteins, for example, TCR. This is in line with an earlier study 24 demonstrating that a similar chimeric receptor containing the TCR transmembrane and cytoplasmic domains and CD8␣ hinge region was not associated with endogenous subunits of the TCR complex.
Expression of scC2Fv/CD8/ in primary T lymphocytes Con A-activated DBA/1 splenocytes were transduced with scC2Fv/CD8/ or the control construct pBabe neo. Two days after transduction, the composition of this cell population and expression of scC2Fv/CD8/ on the cell surface were determined by staining with appropriate antibodies and FACS analysis. The cell population contained 40.1 ± 2.1% (mean ± s.d., three experiments) of CD4 + cells and 52.9 ± 6.1% (mean ± s.d., three experiments) of CD8 + cells. The percentage of CD4 + and CD8 + cells was unaffected by the nature of the gene transduced into them. Results of a representative FACS analysis are shown in Figure 5 .
11.2 ± 3.7% (mean ± s.d., three experiments) of Con Aactivated splenocytes transduced with a control construct were positive upon staining with anti-mouse mAb C2 antiserum. This background staining was due to the presence of B cells expressing IgG on their surface, because the same proportion of cells in this population were stained with anti-mouse chain mAb OX-20 (not shown). After transduction with scC2Fv/CD8/, the number of splenocytes, which were positive upon staining with anti- mAb C2 antiserum was higher and constituted 14.9 ± 3.3% (mean ± s.d., three experiments). Thus, as calculated by subtracting the background staining mediated by B cells, 3.7% of T cells expressed the chimera on the cell surface after transduction with scC2Fv/CD8/. A representative FACS analysis is shown in Figure 6 .
Proliferative response of CII-stimulated primary lymphocytes transduced with scC2Fv/CD8/ Con A-activated splenocytes were transduced with the gene encoding scC2Fv/CD8/. Control splenocytes were transduced with pBabe neo. The transduced cells were expanded for 1 day with IL-2 to allow for the expression of the transduced genes, and then stimulated with CII or Gene Therapy plastic-immobilised anti-CD3⑀ mAb for 1 or 2 days. In five independent experiments, stimulation with CII immobilised on plastic or added to culture medium increased proliferation of scC2Fv/CD8/-transduced Con A-activated splenocytes, but not control pBabe neotransduced cells. In addition, in three of these experiments, scC2Fv/CD8/-transduced Con A-activated splenocytes demonstrated higher spontaneous levels of proliferation than control pBabe neo-transduced cells. This was more obvious on day 1, and the difference decreased on day 2. Results of one such experiment are presented in Figure 7 . When stimulated with anti-CD3⑀, mock-transduced cells and cells transduced with pBabe neo or the scC2Fv/CD8/ gene displayed equivalent levels of proliferative response. Obviously, the response to anti-CD3⑀ was predominantly mediated by non-transduced lymphocytes that constituted the majority of cells in these populations. It is, therefore, impossible to conclude from these data whether or not a loss of TCRmediated responsiveness similar to the one observed in the scC2Fv/CD8/-expressing T cell hybridomas ( Figure  3 ) occurred in scC2Fv/CD8/-expressing primary T cell. 
Figure 7 Proliferation of scC2Fv/CD8/-expressing primary lymphocytes in response to CII. Con A-activated splenocytes were transduced with pBabe neo (control) or with the scC2Fv/CD8/ gene (scC2Fv/CD8/). After 1 day in culture with 20 U/ml of IL-2, the transduced cells (5
Discussion
The chimeric receptor scC2Fv/CD8/ is designed to initiate in T cells, upon cross-linking, signalling events similar to those seen during antigen-induced activation. Among other features characteristic for activated T cells, scC2Fv/CD8/-mediated activation might include changes in the expression of cell adhesion molecules and chemokine receptors mediating retention of T cells at the sites where they encounter APC-presented cognate antigenic peptides. Since the exact nature of such changes is unknown, it is difficult to address experimentally the question whether or not they are induced by stimulation of scC2Fv/CD8/-expressing T cells with CII. As experimental evidence suggesting that scC2Fv/CD8/ can initiate intracellular signalling events in T cells similar to those initiated upon ligation of their TCR complex, we demonstrate that transduction with the chimera enabled T cell hybridomas to secret IL-2 and primary T lymphocytes to proliferate in response to stimulation with CII (Figures 2 and 7) .
According to the most widely held stoichiometric model of the TCR, 32,33 a single receptor consists of two clonotypic subunits ␣ and ␤ noncovalently associated with signalling proteins including a TCR homodimer, CD3␥, CD3␦, and two CD3⑀. Oligomerisation of the TCR complexes rather than occupancy of the TCR clonotypic subunits appears to be important for antigen-induced T cell activation, because crosslinking of the TCR complexes with antibodies specific to extracellular domains of the TCR signalling proteins induces cellular responses normally elicited by binding MHC/peptide complex to the TCR clonotypic subunits. Furthermore, TCR function can be mimicked by ITAM-containing chimeric proteins consisting of the TCR signalling subunits fused with various ectodomains and expressed in T cells without association with the clonotypic subunits.
The capacity of scC2Fv/CD8/ to function as a surrogate antigen receptor in T cells depends on how efficiently it forms clusters upon ligand binding. The ability to form clusters, in turn, depends on ligand-binding affinity and valency of the receptor. The anti-CII mAb C2 was selected as a source of the scC2Fv/CD8/ CIIbinding ectodomain on the basis of its high affinity to CII. 25 K d s of antigen/MHC complex binding to TCR does not exceed 10 −7 m 34 that is lower than K d s of high affinity antibodies, and the ligand binding affinity of scFv is usually comparable with that of a native antibody. 35 Besides, in contrast to TCR, scC2Fv/CD8/ forms multivalent receptor complexes. These considerations allow for the suggestion that the surrogate T cell receptor scC2Fv/CD8/ might have a greater potential to oligomerise upon ligand binding than an average TCR.
With regard to the features of a chimeric ITAM-containing receptor that affect its cross-linking requirements, it is interesting to compare scC2Fv/CD8/ with another chimeric protein containing the ectodomain of the same kind as scC2Fv/CD8/ but different signalling subunit. 29 The transmembrane and cytoplasmic domains of this chimera, scC2Fv/␥, are represented by corresponding domains of Fc⑀RI signalling ␥ subunit, hence, it contains one ITAM. This chimeric receptor forms homodimers that are divalent receptors containing two ITAMs. In T cells, it can also associate with endogenous TCR producing monovalent heterodimers with four ITAMs. In different types of T cell hybridomas, either the homodimers or heterodimers are predominantly expressed. 29 MD.45 T cell hybridoma transduced with scC2Fv/␥, which expressed predominantly homodimers, was responsive to CII added to culture medium as well as to CII immobilised on plastic. Meanwhile, chimera-transduced HCQ6 T cell hybridoma, which expressed predominantly heterodimers, demonstrated more stringent cross-linking requirements, because it was responsive to plasticimmobilised CII, but not to CII added to culture medium. Similarly to the scC2Fv/␥-transduced HCQ6 cells expressing predominantly homodimers of the chimera, T cell hybridomas expressing scC2Fv/CD8/ that forms exclusively divalent homodimers ( Figure 4) were responsive not only to plastic-immobilised CII but also to CII added to culture medium. Therefore, valency of the ectodomain appears to be a more important factor determining the cross-linking requirements of these CII-specific chimeric receptors than their ITAM content.
Indeed, production of pro-inflammatory cytokines by engineered lymphocytes stimulated by CII in articular cartilage could be a major disadvantage of this approach.
Gene Therapy
This consideration is particularly important taking into account that the engineered CII-specific T lymphocytes may reach sites other than articular cartilage such as the intervertebral disc, eye and costal cartilage where CII is present. These potentially harmful consequences, however, may be avoided by using T lymphocytes not producing pro-inflammatory cytokines, for example Th2 cells, for engineering carriers of therapeutic genes. Furthermore, constitutive production of an anti-inflammatory cytokine from the gene introduced into potentially pathogenic CD4
+ T lymphocytes seems to overcome their pro-inflammatory properties. 4, [12] [13] [14] [15] [16] [17] As demonstrated in our previous study, 29 T cell hybridomas expressing scC2Fv/␥ were unresponsive to stimulation through their endogenous TCR. Presumably, this resulted from reduced expression of endogenous TCR and CD3⑀ in these scC2Fv/␥-expressing T cell hybridomas. A similar decrease in TCR-mediated responsiveness in scC2Fv/CD8/-expressing T cell hybridomas is demonstrated in the present study ( Figure 3) . Thus, chimeric ITAM-containing proteins expressed in T cells may inhibit function of endogenous TCR regardless of the nature of their ITAM. This inhibition might be mediated by interfering with the assembly or recirculation of the TCR complexes. Competition for secondary messengers is also a possibility.
Materials and methods
Tissue culture and antibody production MD.45 is a H-2 b restricted CTL hybridoma generated from a BALB/c mouse, 36 donated by Z Eshhar (The Weizmann Institute of Science, Rehovot, Israel). HCQ6 is a CII-specific H-2 q restricted CD4 + hybridoma generated from a DBA/1 mouse, 37 donated by R Holmdahl (Lund University, Lund, Sweden). Hybridoma producing CIIspecific mAb C2 was a gift from L Klareskog (Karolinska Hospital, Stockholm, Sweden). All T cell hybridomas were cultured in DMEM supplemented with 10% FCS (Gibco BRL, Life Technologies, Renfrewshire, UK). Generation of the polyclonal anti-mAb C2 antiserum is discribed elsewhere.
29 GP+E86 cells, an NIH 3T3-based ecotropic murine packaging cell line, 38 were cultured in DMEM supplemented with 10% NBCS (Gibco).
Splenocytes isolated from normal DBA/1 mice were stimulated in vitro with 2.5 g/ml of Con A (Sigma, Poole, UK) for 3 days. To remove nonviable cells, these Con A-activated splenocytes were centrifuged on a Lymphoprep (Robin Scientific, Solihull, UK) density gradient. Cells from the interface were expanded in 20 U/ml of human recombinant IL-2 (gift from Hoffman la Roche, Nutley, NJ, USA) for 1 day before transduction with a retrovirus. Primary lymphocytes were cultured in DMEM supplemented with 10% FCS and 50 mm 2-ME.
Construction of chimeric genes in a retroviral vector
Plasmid pBabe neo+scC2Fv/␥ contains the scFv of the anti-CII mAb C2 fused with the signalling ␥-subunit of Fc⑀RI. 29 A DNA fragment containing scC2Fv/␥ was amplified from pBabe neo+scC2Fv/␥ by PCR using oligonucleotide primers 5Ј-TGGATCCTGAACACACATC CCTTACCATGG and 5Ј-GTCTAGATGAG-GAGACTG TGAGAGT containing NotI and ApaI restriction sites at the 5Ј and 3Ј ends, respectively. The PCR product was digested with NotI and ApaI, and subcloned into the plasmid pcDNA3 digested with the same enzymes. The pcDNA3 with scC2Fv/␥ in it was cut with BsteII, filledin with Klenow fragment to form blunt ends and digested with NcoI. The product was a DNA fragment encoding the entire scFv of the mAb C2 with a NcoI restriction site at its 5Ј end and blunt 3Ј end. A DNA sequence encoding the hinge region of murine CD8␣ and the transmembrane and cytoplasmic domain of murine TCR (hCD8␣-TCR) was cut out of p2␦RICD8- 39 (donated by T Brocker, Max Planck Institute for Immunobiology, Freiburg, Germany) by digestion with EcoRI, blunting with Klenow fragment of DNA polymerase, and partial digestion with BamHI. It had blunt 5Ј end and BamHI restriction site at its 3Ј end. The plasmid miniMFG was derived from the plasmid MFG 40 by deleting a 2.2 kDa fragment between HindIII and Bst1107I restriction sites. The BsteII-blunted/NcoI-cleaved scC2Fv was subcloned at one time with the EcoRI-blunted/BamHIcleaved hCD8␣-TCR into NcoI/BamHI-cleaved miniMFG, the C2VH-(GGGGS) 3 -C2VL in front of the hCD8␣-TCR, to yield miniMFG+scC2Fv/CD8/ containing the final insert C2VH-(GGGGS) 3 -C2VL-hCD8␣-TCR.
Retrovirus production and transduction of lymphocytes Transfection of GP+E86 cells was carried out by calcium phosphate precipitation and glycerol shock as described previously. 41 The cells were cotransfected with 20 g of DNA from miniMFG+scC2Fv/CD8/ and 1 g of DNA from pSV2 neo. Transfected cells were selected in 1 g/ml G418. T cell hybridomas HCQ6 or MD.45 were transduced by co-culture overnight with the permanently transfected GP+E86 cells. The hybridoma cells expressing scC2Fv/CD8/ on the cell surface were isolated by limitting dilutions. Two series of clones, MD.45(C2CD8) and HCQ6(C2CD8), were established. T cell hybridomas transduced with pBabe neo or ␤-galactosidase gene in a retroviral vector are described elsewhere. 29 Con A-activated splenocytes were transduced with scC2Fv/CD8/ using virus-containing supernatants of scC2Fv/CD8/-transfected packaging GP+E86 cells. Control lymphocytes were treated with supernatants of nontransfected GP+E86 cells (mock-transduced), or with supernatants of GP+E86 cells producing retroviral particles incorporating the retroviral vector pBabe neo. 42 For collection of the supernatants, subconfluent monolayers of packaging cells were cultured overnight in fresh DMEM supplemented with 10% FCS and 50 m 2-ME. Freshly collected supernatants were filtered through 0.45 m filters and supplemented with 8 g/ml of polybrene (Sigma). The lymphocytes were resuspended in the retroviruscontaining supernatants and centrifuged for 6 h at 2500 g at 20°C to enhance the infectivity of retrovirus. 43 After infection, the cells were cultured for 1 day in 20 U/ml of IL-2 and used in functional experiments, or cultured for 2 days in 20 U/ml of IL-2 and used for FACS staining.
Biotinylation of cell surface proteins
To label cell surface proteins with biotin, viable cells were washed five times in PBS with 1 mm CaCl 2 and 1 mm MgCl 2 and resuspended in the same buffer (5 × 10 6 cells/ml). Sulfosuccinimidyl 6-(biotin-amido) hexanoate (Pierce, Rockford, IL, USA) was added from stock solution in DMSO to a final concentration 0.1 mg/ml. The cells were incubated for 1 h on ice and washed five times in PBS.
Immunoprecipitation and immunoblotting
Surface-biotinylated or non-labelled cells were solubilised by incubating for 30 min on ice in lysis buffer containing 50 mm Tris-HCl pH 7.5, 150 mm NaCl, 1% NP40 (BDH, Poole, UK), 1 g/ml leupeptin, 1 g/ml chymostatin, 1 g/ml pepstatin A, 1 mm PMSF, 1 mm aprotinin, 10 mm iodacetamide (all from Sigma) and centrifuged at 10 000 g for 15 min. Immunoprecipitation of scC2Fv/CD8/ from nuclear-free lysates of surface-biotinylated cells was carried out using Protein A-Sepharose beads (Pharmacia, Herts, UK) with covalently bound IgG from the rabbit anti-C2 antiserum. Briefly, Protein ASepharose beads were incubated with the rabbit anti-C2 antiserum and 20 mm dimethyl pimelimidate (Pierce) in 0.2 m borate buffer pH 9 for 45 min at room temperature. The reaction was stopped with 0.2 m ethanolamine pH 8, and the beads were washed five times in PBS. The nuclear-free supernatants of lysed surface-biotinylated cells were incubated with the anti-C2 IgG-coupled Protein A-Sepharose beads for 4 h at 4°C. After immunoprecipitation, the beads were washed five times with lysis buffer.
Nuclear-free lysates of non-labelled cells, or immunoprecipitated proteins from lysates of surface biotinylated cells, were separated by SDS-PAGE and transferred on to nitrocellulose membrane, which was then blocked with non-fat milk. Biotinylated scC2Fv/CD8/ was detected by blotting with streptavidin-biotinylated horseradish peroxidase complex (Amersham International, Bucks, UK). Non-labeled scC2Fv/CD8/ was detected by immunoblotting with 1:1000 dilution of rabbit anti-C2 antiserum followed by F(ab) 2 -fragment of donkey anti-rabbit IgG conjugated with horseradish peroxidase (Amersham International). All blots were developed using a chemiluminescence kit (ECL; Amersham International) and exposed to an X-ray film (Kodak-Pathe, Paris, France).
Flow cytometry
For detection of cell surface-expressed scC2Fv/CD8/, cells were stained with 1:200 dilution of the rabbit anti-C2 antiserum followed by FITC-labelled F(ab) 2 fragment of goat anti-rabbit IgG Ab (Sigma). Expression of CD4 and CD8 was determined by staining with rat anti-mouse CD4 mAb KT-6-1sle and rat anti-mouse CD8 mAb 53.6.72-14, respectively. 44 B cells were detected with antichain mAb OX20 (Pharmingen, San Diego, CA, USA). PEconjugated F(ab) 2 fragment of goat anti-rat IgG (Serotec, Oxford, UK) was used as a secondary Ab. Armenian hamster anti-CD3⑀ mAb 145-2C11 and normal hamster IgG as a control were used for detection of CD3⑀ expression on the surface of T cell hybridomas. FITC-labelled goat IgG specific to Armenian hamster IgG was used as a secondary reagent. The samples were analysed by FACS (Becton Dickinson, Mountain View, CA, USA) using CellQuest software.
Cell stimulation CII was purified from bovine articular cartilage. 45 For stimulating T cell hybridomas or Con A-activated splenocytes, CII was used attached to the wells of a flat bottom 96-well plate, or added to culture medium. In some cases, cells were stimulated with plastic-immobilised anti-CD3⑀ mAb 145-2C11. Concentration of murine IL-2 in the culture supernatants of hybridoma cells was determined by ELISA. The mAb JES6-1A12 (Becton Dickinson, Oxford, UK) was used for coating ELISA plates. Biotinylated mAb for detection in IL-2 was JES6-5H4 (Becton Dickinson). The detection limit of the IL-2 ELISA was 15 pg/ml. 3 H thymidine was added to cultures of Con Aactivated splenocytes (1 mCi per well of a 96-well plate) for the last 5 h of stimulation with CII or anti-CD3⑀.
